Cartesian Therapeutics
RNAC
RNAC
61 hedge funds and large institutions have $136M invested in Cartesian Therapeutics in 2020 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
43% more capital invested
Capital invested by funds: $95M → $136M (+$41.2M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.6% less ownership
Funds ownership: 2.78% → 2.18% (-0.6%)
Holders
61
Holding in Top 10
1
Calls
$70K
Puts
$1K
Top Buyers
| 1 | +$18.9M | |
| 2 | +$4.09M | |
| 3 | +$2.85M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$2.68M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$2.1M |
Top Sellers
| 1 | -$2.88M | |
| 2 | -$1.98M | |
| 3 | -$1.09M | |
| 4 |
O
OrbiMed
New York
|
-$687K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$395K |